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Abstract 
Vitamin D status among pre-school children in rural Nepal determined by using dried 
blood spot sampling.  
Diana Avagyan
1
, Sudan Prasad Neupane
2
, Thomas E. Gundersen
3
, Ahmed A. Madar
4  
1 
Department of Community Medicine, Institute of Health and Society, University of Oslo, Norway 
2 
Norwegian Centre for Addiction Research (SERAF), Institute for Clinical Medicine, University of Oslo, 
Norway 
3
Vitas as, Oslo Innovation Park, Oslo, Norway 
4 
Institute of General Practice and Community Medicine, University of Oslo, Norway 
Insufficiency of vitamin D, which plays a major role in the calcium and bone metabolism, is 
reported from populations worldwide. Its extra skeletal benefits are being identified, vitamin 
D is important in function of immune and CV systems. However, little is known about the 
vitamin D status among populations from developing country settings, particularly in 
children.  
Objective: we aimed to assess the vitamin D status and contributing factors among children 
between 1 to 5 years of age in rural Nepal at latitude 27.39
0 
N. 
Materials and methods: A total of 280 children aged between 1 and 5 years were randomly 
selected from the records of vitamin A supplementation program and included in the study. 
Blood samples were collected using the dried blood spot technique. The level of serum 25-
hydroxyvitamin D3 (25(OH)D3) and D2 (25(OH)D2)  were measured in whole dried blood 
spots by using liquid chromatography- tandem mass spectrometry analysis. For the 
assessment of calcium intake and background variables we used structured questionnaire. 
Results: Hypovitaminosis D, defined as a 25(OH)D3 level less than 50nmol/l was identified in 
91.1% of children. There was no association between level of 25(OH)D3 and gender, socio-
economic indicators, sun exposure or nutritional status.  
Conclusion: vitamin D deficiency is common among children from 1-5 years of old living in 
rural Nepal. 
Keywords: Vitamin D deficiency, Dried blood spot, Child health, South Asia 
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1. Chapter I, Introduction 
1.1 Literature review  
1.1.1 Vitamin D photobiology and physiology 
Vitamin D is prohormone that plays an essential role in the mineralisation of bones (1). There 
are two ways for humans to meet requirement for vitamin D, the major amount produced in 
the skin after exposure to the sunlight and the rest is be fulfilled from dietary sources. There 
are few foods that are naturally rich with vitamin D, although there are some fortified 
products available for consumption (2).  
Vitamin D exists in two forms, vitamin D2 (ergocalciferol) generated from ergosterol in 
plants and vitamin D3 (cholecalciferol) is produced in the skin of humans as well as by some 
animals from 7-dehydrocholecalceferol (7DHC), both reactions are prompt due to exposure to 
sunlight (3). 
The process of vitamin D production in human’s cutaneous from 7DHC consists of two main 
stages. In the skin 7DHC under the impact of UVB radiation with the wavelengths 290-315 
nm enters into the reaction of isomerisation and generates previtamin D3. Subsequently, 
previtamin D3 undergo a reaction prompt by the skin temperature and with help of membrane 
fatty acids is transformed into the vitamin D3. The next step is shifting vitamin D3 from the 
skin to the circulation by vitamin D binding protein (DBP). Obviously, it is not possible to 
develop hypervitaminosis  due to excessive insolation,  the excess of vitamin D is destroyed 
by photodegradetion in the skin by UVA, in this way mankind maintains homeostasis and 
provides tissues and organs with essential amount of vitamin D (4).  
The further metabolism of vitamin D is happening in the liver and kidneys. Vitamin D that 
was produced in the skin or taken from diet is processed in the liver by cytochrome P450s  to 
25-hydroxyvitamin D (25(OH)D) (5).  
25(OH) D is main circulated form out of whole pool of vitamin D metabolites and it has half-
life of two-three weeks. Therefore for the assessment of vitamin D status the 25(OH) D is 
most appropriate metabolite to be measured, which reflects well with secondary   
hyperparathyroidism, rickets and osteoporosis (5).  Subsequently, in the kidneys 25(OH) D is 
metabolised by 1 – alpha hydroxylase to the biological most active form is 
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1,25dihydroxyvitamin D (1, 25(OH)2D). All farther effects of vitamin D on the health of 
humans occurs through the acting of 1,25dihydroxyvitamin D (6).   
1.1.2 Effect on the skeletal system 
 
1, 25 (OH)2D plays an essential role to sustain the constant level of calcium and phosphorus 
in the circulation. The key point of the regulation is presence of vitamin D receptors (VDR) in 
the small intestinal cells and in osteoblasts of skeletal system. By the interaction with VDR,  
1, 25 (OH)2D   increases the reabsorption of calcium and phosphorus in the small intestine. In 
case of insufficient dietary intake of calcium, 1, 25 (OH)2D interacts with VDR in osteoblasts. 
This interaction mobilizes the calcium storage from the bones by activating the proliferation 
process of osteoclasts (6).  
In the conditions of vitamin D deficiency, the absorption of calcium and phosphorus in small 
intestine may decrease up to 85-90% and 40% respectively (5). It leads to declining the level 
of ionized calcium in serum; the low level of ionized calcium in serum causes irritation of 
calcium sensors in the parathyroid glandules. In response, parathyroid glandules produces 
more parathyroid hormone (PTH). As a result of hyper secretion of PTH, the reabsorption of 
calcium in the kidneys’ tubular system is elevated, while phosphorous is loosed with urine. In 
addition, PTH dissolves bones to maintain normal Calcium level in the serum. Moreover, in 
the state of secondary hyperparathyroidism the conversion of 25(OH) D into 1, 25(OH)2D is 
enhanced. Therefore, it is not informative to measure the levels of 1, 25(OH)2D or calcium, 
because its remains normal while person might have deep deficient of vitamin D (6). 
Vitamin D deficiency leads to comprehensive failure in the mineralization of the bones and 
development of osteomalacia for children when skeletal system is immature it manifests in 
form of rickets and for adults osteoporosis(6) .Additionally, it is known that children with 
vitamin D deficiency status in early life develop grow retardation, it may have implication for 
the future life due to inability to achieve genetically inherent height (3).   
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1.1.3 Extra skeletal effects of vitamin D 
 
During recent years the role of vitamin D for human health is reappraised. The numbers of 
review articles have been published to summarise the extra skeletal effects of vitamin D (7-
12).  It has been suggested that the compensate state by vitamin D is not only essential for 
normal development and function of skeletal system but also may play important role in the 
prevention of autoimmune, neoplastic and cardiovascular diseases. (7). Moreover, there is 
evidence that vitamin D deficiency may contribute to the incidence and the severity of acute 
low respiratory tract infections as well as progression of tuberculosis to its active form (12-
14). 
Due to discovery that the nuclear VDR presents in the majority of human’s tissues (7), and 
understanding that the most type of cells are able to transform vitamin D into the its active 
form 1, 25(OH)2D, the interest to non-skeletal effects of vitamin D appears (15). 
1, 25(OH)2D is recognized as a steroid hormone that acts as a gene expression factors.  1, 
25(OH)2D is attaching to the VDR with association of ligand-activated transcriptional factors 
and displaces into the nucleus. Inside of nucleus 1, 25(OH)2D binds to the special DNA 
sequences recognized as the vitamin D response elements (VDRE) (7). Hereby, vitamin D 
regulates expression of more than 200 genes with transcription of various proteins. Hence, 
these proteins adjust cellular differentiation, proliferation and apoptosis with consequent 
effects on the function of many organs and systems (14, 16). 
As a matter of fact, for paediatric group the potential effect of vitamin D on immune system 
and risk of acquiring respiratory infections is more crucial and influential on public health 
indicators.    
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   Figure 1:  Vitamin D’s pathways  (16)                                                             
1.1.4 Potential effects of vitamin D on the Immune system 
 
As pertaining to immune system, the skin, gastrointestinal tract and respiratory tract serve as 
an ordinary portal of infections entry. While, as a part of innate immune system epithelial 
cover together with macrophages and neutrophils provide barriers against infection(17).  
Circulated 25(OH)D is absorbed by macrophages, neutrophils and epithelial cells. In the 
cellular level under the impact of extra renal 1 alpha hydroxylase 25(OH)D converted into the 
active form 1,25 (OH)2D. Consequently active vitamin D banded to VDR and after the 
translocation into the nucleus attaches to the VDRE (16). It is known that gene encoded for 
cathelicidin accommodate VDRE (18). Cathelecidin is antimicrobial peptides  produced by 
epithelial cells and neutrophils and relates to the function of innate immune systems(15). (See 
figures1, vitamin D’s pathways) 
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1,25(OH)2D-VDRE complex turn on the gene responsible for the synthesis of cathelicidin 
(hCAP18). Cathelicidin undergoes through the segmentation and is transformed into the 
active form IL37(16). In fact, IL37 manifests antimicrobial activities against bacteria, virus and 
fungi(15) .  
Additionally, on the surface of macrophages there are Toll-like receptors (TLRs) they play 
role of sensors to recognize bacterial lipoprotein and forward signal to macrophage for 
synthesis of –cathelicidin.  As a part of this signalling system, when Toll-like receptors are 
triggered by bacteria’s lipoprotein it is boost VDR and extra renal 1 alpha hydroxylase, it 
leads to the enhancement of the cathelicidin’s production (16). 
The recent immunological data indicates that conversion of vitamin D into the active form 
1,25(OH)2D is permanent process in the epithelial cells of respiratory tract and it accelerates 
during the viral infection (19). Therefore, sufficient status of vitamin D is essential for the 
adequate cathelicidin production as a part of defence reaction against respiratory infections 
(15). 
Numbers of epidemiological studies have been conducted that have looked into possible 
association of vitamin D deficiency and acute low respiratory tract infections among 
paediatric group (20, 21). Results from case-control studies conducted in India (22), 
Bangladesh (23) indicated strong association between vitamin D deficiency with acute low 
respiratory tract infections (ARTI).   However, this association has not been proved for 
Canadian children with bronchiolitis, studied by Roth et al. in 2005 (24); although,  the 
authors suggested that it could be due to different etiological factors that cause ALRI in 
developing countries and in developed one such as Canada(24). Later, McNally et al. 
conducted another case- control study in Canada, it has compared vitamin D status between 
children with pneumonia and healthy ones (25).The result has provided some new concept. It 
has been suggested that vitamin D deficiency is not associated with incidence of ALRI, but 
with severity of respiratory infections among paediatric group (25). This conclusion has been 
confirmed by hospital based retrospective case study from Japan(26). Furthermore, 
complementary analysis of the Canadian study by Roth et al. from 2005 (24), identified 
association between  genotype ff with less active VDR in  the epithelial cells of respiratory 
tract (12). It has been show that children with genotype ff susceptible to ARTI particularly 
towards RSV (respiratory syncytial virus) bronchiolitis, because of inability of vitamin D to 
implement immunomodulatory and antimicrobial effects (12, 27). Additionally, data from 
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study conducted in a vitro model suggested that vitamin D highly likely diminishes 
inflammation in respiratory tract caused by RSV (19), also there is evidence that vitamin D is 
able to suppress release of pro inflammatory cytokines by macrophages (18).  
In fact, interventional randomized control trials were called to resume the vitamin’s D effects 
on the susceptibility towards acute low respiratory tract infections in paediatric group.  
Several trials have been conducted at the different settings among the population at high risk 
of vitamin D deficiency (28-30). The results vary from positive effect on the reduction of 
incidence of repeated cases to no effect of intervention. Nevertheless, it has been suggested 
that intervention may require adjustment in dosage and regiment or effect from 
supplementation may be different for the different age groups and further research is needed  
(31).   
As regards to the association of vitamin D status and tuberculosis, the meta-analysis and 
systematic review published in 2008, concluded that there is a strong correlation between 
vitamin D insufficiency and risk of development active tuberculosis (13). In addition the 
result from cohort study indicates, that the low status of vitamin D increases the probability to 
develop acute tuberculosis by 5 folds among healthy household contacts(32). The reason is 
that in the low vitamin D status the synthesis of antimicrobial peptide catelicidin by 
macrophages and respiratory epithelial cells is decreased, hence increase susceptibility 
towards Mycobacterium Tuberculosis (13, 32, 33). 
1.1.5 Determination of vitamin D status   
 
For the assessment of vitamin D status it is recommended to measure 25(OH)D; it has half-
life of 2-3 weeks and considered as the most reliable metabolite that reflects the body’s 
vitamin D stores. In contrast as it was discussed above the measurement of its active 
metabolite 1,25(OH)2D is not informative, and is recommended only if there is suspicion on 
impaired production of 1,25(OH)2D by kidneys in terms of rare inherit or acquired disorders 
(34).   
As regards to the measurements techniques of various methods are available such as 
radioimmunoassay and high-performance liquid chromatography. However, up to day the 
most accurate method to quantify 25(OH)D is  liquid chromatography – tandem mass 
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spectrometry (LC-MS/MS), it allows to measure 25(OH)D2 and 25(OH)D3 separately and  is 
considered as a gold standard(35). 
In addition, during recent years the dried blood spot(DBS) sampling methods along with LC-
MS/MS has been suggested as a new approach for the clinical testing and screening(36). This 
novel method of sampling brings better opportunities for the assessment of vitamin D status. 
First of all it is less invasive and consequently reduces the risk of infection’s transmission; 
secondly for the assessment the amount of required blood is remarkably less, what makes it 
convenient for paediatric patients. Another advantage it does not require sophisticated 
equipment for storing and shipping materials, so can be used for field research in the resource 
poor setting (36).And the most important, it has shown good correlation between LC-MS/MS 
method using DBS with serum. As a result LC-MS/MS method using DBS for assessment of 
vitamin D considered to be high sensitive and correlated good with serum level(37-39).  
As regards evaluation of vitamin D status, so far there is not unified agreement for the 
definition of vitamin D sufficiency and insufficiency. For the determination of cut off level 
were suggested various methods. The most common way of determining normal level of 
vitamin D is to identify the minimum level of 25(OH)D which maximum suppress the 
secretion of PTH, consequently plateau of PTH was observed at level 30ng/ml (34). However, 
there is some discrepancies, it was identified that for some individuals there is no correlation 
between level of 25(OH) D and PTH. Moreover, the deviation in the level of PTH does not 
always related to the changes in the vitamin D status during childhood, because of elevated 
calcium absorption in the period of active growth (40).  
There are also different suggestion regarding the normal range of vitamin D, such as 
determine the level of 25(OH) D that ensures maximal absorption of calcium in the intestinal, 
or the level when the majority does not have any manifestation of diseases associated with 
vitamin D metabolism. However, both of these suggestions are also debateable (40). 
In fact, until recently the most widely accepted definition of vitamin D status was the one 
suggested by Lips P. (41), where vitamin D deficiency subdivided on mild, moderate and 
sever deficiency. 
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Table 1: Definition of Vitamin D status   
Vitamin D status Level of 25(OH)D 
Severe deficiency  0-12.5 nmol/l 
Moderate deficiency 12.6-25 nmol/l 
Mild deficiency 25.1-49.9 nmol/l 
Sufficient ≥ 50 nmol/l 
Although, these criteria still widely accepted by clinicians (see table above), the Endocrine 
Society’s Clinical Practice Guidelines suggested the new criteria for both children and adults 
(see table below)  (42). 
 
Table 2: Definition of vitamin D status by Endocrine Society’s Clinical Practice Guidelines 
Vitamin D status Level of 25(OH)D 
 ng/ml                              nmol/litre 
Deficiency 20                                     50 
Insufficiency 21-29                               52.5-72.5 
Sufficient 30                                     75 
Ideal 30-60                               75-150 
Safe  <100                                250 
It has been suggested, that the level of 25(OH)D 10ng/ml is needed to maintain  the bone 
metabolism (40), although the level of vitamin D that requires to perform extra skeletal effects 
is greater and more likely is 30ng/ml (18). 
Additionally, it is recommended for assessment of child’s vitamin D status to measure level of 
calcium, phosphorus and alkaline phosphatase. Alkaline phosphatase is marker of bone turn 
over and the level of calcium will be deviated when the bone stores are depleted. So, these 
indicators are only informative when child is severe deficient and bone metabolism is 
involved (40).  
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1.1.6 Risk factors for developing hypovitaminosis D 
 
Geographical determinants, it is known that living above 35
0
N latitude is heightening the risk 
of vitamin D deficiency during winter months. The reason is that considerably less UVB 
photons are able to reach the Earth’s surface in that latitude; the UVB photons are absorbed 
by the ozone layer in the stratosphere when the zenith angle is oblique as it is happening 
during winter months (3). Moreover, it has been recently proved by Holick et al. (43) in vitro 
models that not only latitude does matter but also the height above sea level. The altitude has 
considerable effect on the production of vitamin D from 7DHC. It has been compared the 
production of vitamin D in three different altitudes in India and Nepal during last week of 
October to first week of November, Agra 169m above sea level, Kathmandu 1400m, 
mountain Everest 5350m. The differences were remarkable, in has been concluded that in the 
latitude 27
0
N on the area with altitude below 3400m production of vitamin D declined 
significantly (43).  Another factor is pollution; atmospheric pollution may have great impact 
on the vitamin D status, through enhancement of UBV photons absorption. Although it is 
more essential for inhabitant of big industrialized cities with high level of emission (44). 
No less important are skin pigmentation and use of sunscreen. Skin pigmentation is 
determined by melanin, which produced in the basal layer of epidermis by melanocytes. 
Melanin works as a photo protector, it has great capacities to absorb UVB and decrease 
syntheses of vitamin D (43). As well as the proper use of sunscreen with protection factor 8, 
consumes up to 95% of UBV photons, and respectively reduce the production of vitamin D in 
the skin (43). 
Another determinant is restriction of sunlight exposure it could be due to clothing habits or 
limitation of outdoor activities. Also, scarcities of products in the diet naturally reach with 
vitamin D and absents of food fortification policy in the country would have certain impact on 
the vitamin D status of population (45).   
Additionally, exclusively breastfeeding is predisposal factor for the development of vitamin D 
deficiency. It is known that the breast milk contains not enough vitamin D to provide child 
with daily requirement, it consist even less when women is vitamin D insufficient. 
Consequently it is recommended to ensure sun exposure for infants when it is possible, or 
provide supplementation (1).   
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Yet other risk factors for the developing of vitamin D insufficiency or deficiency are the 
conditions that cause malabsorption, hence decrease the intake of vitamin D from intestine. 
Also, the important role plays the treatment with medication that is likely to interfere with 
vitamin D metabolism (Phenytoin, Phenobarbital, Carbamazepin, Izoniazid, Theophylline, 
Rifampin) (1). 
During recent years one more determining factor was lifted up. It has been shown that people 
with obesity at the risk of vitamin D insufficiency due to reduced bioavailability of vitamin D. 
In other words they develop relative insufficiency because vitamin D deeply sequesters in the 
fatty tissue and cannot replenish the circulating pool of vitamin D(46). 
Each of these factors may contribute to the development of vitamin D deficiency in a certain 
extent. For South Asian region, skin pigmentation, clothing style, traditional diet and 
exclusively breastfeeding are the major factors. Additionally for the industrial population it is 
account pollution and time spend outdoor (45). 
1.1.7 Recommendations for vitamin D testing 
 
According to the resent scientific data it is advised to test those who are at risk of 
development insufficiency or deficiency (1, 40, 42): 
- Individuals with darker skin and living at high latitude 
- Individuals with chronic diseases that leads to the malabsorption or those who are on 
the long lasting medication that interferes with vitamin D metabolism 
- Infants with symptoms of rickets  
- Individuals with frequent fractures  
There is not data on the benefits of testing general population (42). 
1.1.8 Recommendation for vitamin D supplementation 
In the recent past the recommendation for vitamin D supplementation regarding infants was 
200 IU/daily, the dosage was calculated based on the evidence that 200 IU/d allows to keep 
the level of 25(OH)D on the level of 11ng/ml (1). However, in connection with recent 
knowledge of normal vitamin D status, the recommendation was revised. The most updated 
recommendations based on the suggestion of maintaining the level of vitamin D equal to 
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30ng/ml. The Endocrine Society’s Clinical Practice Guidelines suggested the following 
dosage for the prevention (table 4) and for the treatment (table 5) of vitamin D deficiency 
(42). 
 
Table 3: Recommendation regarding vitamin D intake for the prevention of deficiency   
Group of Individuals  Vitamin D3 or Vitamin D2 
Children 0-12 moths 400- 1000 IU
* 
Children 1-8 years 600-1000 IU 
Children (males) 9-18 y 600-1000 IU 
Children (females) 9-18 y 400-2000IU 
Adults  1500-2000 IU 
Pregnancy, and lactation period 1500-2000 IU 
Mother’s requirement during exclusively 
breastfeeding, if child does not take 
supplementation 
 
2000 - 4000 IU 
*
1000 IU= 25 mcg  
Table 4: Recommendation regarding vitamin D intake for treatment of deficiency 
Group of individuals Vitamin D3 or Vitamin D2 
Children 0-12 moths 2000 IU/daily during 6 weeks, after reaching level of 
30ng/ml                   400 IU/daily 
Children 1-18 year 2000 IU/daily during 6 weeks, after reaching the target 
level is 30ng/ml           600 IU/ daily 
Adults  50,000 IU/weekly during 8 weeks, after reaching target 
level is 30ng/ml            1500 IU/daily 
 
Additionally, for obese individuals (BMI 30 kg/m
2
 or more) as well as  for those who are on 
the continuing medication that interferes with vitamin D metabolism it is recommended 
augment the dosage twice (42).  
In fact, the Endocrine Society’s Clinical Practice Guidelines, stated clear that there is no 
evidence regarding differences in outcomes of vitamin D2 or vitamin D3 supplementation; 
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and in addition there is not significant differences whether to comply daily, weekly or 
quarterly regiment (42).   
1.1.9 Vitamin D status around the world 
During recent years numbers of systematic reviews have highlighted worldwide prevalence of 
vitamin D deficiency (45, 47, 48). In fact, the authors were faced with difficulties of 
comparing various studies from different regions. It is known that researcher has been using 
different essay methods to measure the level of 25(OH) D. Additionally, the level of vitamin 
D which is qualified as normal or insufficient quite debatable,  although most of researcher 
agree that the level of 25(OH) D should be at least 50 nmol/l to be considered as sufficient. 
Nevertheless, due to these reviews some general trends are recognizable. It could be 
concluded that vitamin D deficiency is worldwide health issue, although the contributing 
factors varies for different regions (48). For instant, it has been shown that in Europe non-
western emigrants are more prone to the development of vitamin D deficiency due to skin 
pigmentation or peculiarities of cultural clothing style and diet (45). Surprisingly, in 
Scandinavian countries the magnitude of vitamin D deficiency was less than in continental 
Europe, explanation is that in Nordic countries people tend to eat more oily fish and use 
supplementation such as cod liver oil. While in south population tend to use more sunscreens 
and developed the habits of avoiding direct sun exposure due to fear of skin cancer (48). As 
regarding Middle East and Asia it has been determined that for this population vitamin D 
status correlates with the clothing style. The worst vitamin D status was detected among 
veiled women and it improves when clothing changes towards western type (45). Also, it has 
been find out that population from Southeast Asia has more improved vitamin D status that in 
other parts of Asia, and it is correlated with consumption of vitamin D rich sea food. In South 
Asia the situation aggravated with low calcium intake and consequently vitamin D deficiency 
presented together with rickets, osteoporosis and fluorosis (49).    
Moreover, recently global studies on vitamin D status have been conducted. The main idea 
behind global studies is to collect comparable data on vitamin D status among population in 
different countries by measuring it with one assay at one central laboratory. Study population 
for these studies were postmenopausal women with risk of osteoporosis from different 
continents. And the result in general confirms the known pattern. The best vitamin D status 
was determined among Canadians, next is population in US and furthers North Europe then 
Continental Europe and the worst condition in Middle East (45, 48). 
 
22 
1.1.10 Vitamin D status in South Asia 
As it was discussed above, the vitamin D deficiency is prevalent around the globe, and South 
Asian region is no exception. Various reports (45, 47-50) have shown that the average 
circulated vitamin D level in adults in South Asian region ranges from 25 nmol/l to 50 nmol/l 
the same figures relevant to neonates and infants.  
To the best of our knowledge, the little is known about vitamin D status among population in 
Nepal, during literature review, one article was identified on micronutrient deficiency of 
pregnant women during first trimester in rural Nepal (51). It has been demonstrated that the 
prevalence of vitamin D deficiency among pregnant women varied from 4.3% during summer 
hot season to 7.1%; 16.4%; and 24.4%; during fall, spring and winter seasons respectively. 
Another study conducted among alcohol-use-disorders inpatients recorded 64% of vitamin D 
deficiency defined as a vitamin D level less than 50 nmol/l (52).    
Taking into consideration that there is a limited data on the vitamin D status in Nepal, farther 
discussion will be focused on the studies that have been conducted in South Asia but within 
the same geographic latitude. Although, most of the studies have explored vitamin D status 
among pregnant women and adolescent with convenient sampling methods, and consequently 
it affect representativeness of studies’ results but still helps to identify general pattern of 
vitamin D status in the South Asian region. As related to vitamin D status of paediatric group, 
data concentrated predominately on the neonates and infants under six months.  
Study from northern Indian (53) has shown high prevalence of vitamin D deficiency up to 
84% among pregnant women from urban and rural population. The authors identified cut off 
point of 25(OH) D as a level below of that the PTH started to rise and for these study subjects 
it was 22.5ng/ml. Additionally, result has shown no differences between vitamin D status of 
urban and rural population, although it was assumed that rural population have better 
opportunities for sun exposure and consequently should have better vitamin D status.  
Marwaha at al. studied vitamin D status among schoolchildren at age 10-18 years of old from 
two different socioeconomic backgrounds (54). The magnitude of vitamin D deficiency, 
qualified as a level below 20ng/ml, was surprisingly high 92.6% for LSES and 84.9% for 
USES. It is significant that subjects from the both groups had the same amount of sun 
exposure but different amount of calcium intake. Authors had concluded that this finding 
suggested possible effect of nutritional status on the vitamin D level (54). Nevertheless, it has 
not been proven by Puri at al. (55). Authors explored vitamin D status among schoolgirls and 
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possible association with socioeconomic status, it has been shown high prevalence of vitamin 
D deficiency in both strata, but even higher for USES 91.9% compare to LSES 89.6% and it 
was correlated with sun exposure but not with calcium intake. 
In 2009 Sahu at al. published result from the cross-sectional study conducted during 18 
months in India at latitude 26
0
 N (56). It has shown high prevalence of vitamin D deficiency 
among pregnant women and adolescent girls 74% and 88.6% respectively, determined as 
25(OH)D level below 50nmol/l. Although this study has limitation which was discussed by 
authors, in fact it was firs study that identified prevalence among rural population. 
Remarkably, is that authors identified seasonal variation of vitamin D status among 
population living at low latitude.  Similarly, Marwaha at al. (57) identified tremendous high 
prevalence of vitamin D deficiency among pregnant women and their exclusively breast-fed 
infants in Delhi 96.3% and 98.8% defined as a level less that 50 nmol/l, and significant 
seasonal variation on vitamin D status through the year. Also, it has been shown positive 
correlation between vitamin D status of lactating mother and their newborns. Low average 
circulated level of vitamin D among term exclusive breastfeed infants and their mothers has 
been confirmed by Agarval at al. in the study from Delhi (58). It has been identified maternal 
mean level of 25(OH)D 8.89±5.97 ng/ml and 11.55±11.7 ng/ml for infants at 10 weeks and 
8.89±5.97ng/ml for infants at 6 months. Those results concur with the Pakistani study 
published in 1998 by M.Atiq at al. (59), authors reported mean level of 25(OH)D for under 6 
months breastfeed infants equal to 24.74±18.17 nmol/l and 49.97±30.38 nmol/l for older ones.  
Table5, summarize the variation of recorded vitamin D status in different population in the 
region.  
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Table5, Variation of serum 25(OH) levels in the South Asian region 
Location Latitude Type of study Population Mean level 
25(OH)D 
Prevalence  
among study 
population 
Reference 
Pakistan, 
Karachi 
 
 Cross-sectional Breastfeed 
infants(6weeks-
11months) and 
mothers 
Age<6 months  
24.74±18.17nmol/l 
Age>6 months 
49.97±30.38nmol/l 
 Atiq at al. 
(59) 
1998 
India, Delhi  Cross-sectional Healthy urban 
subjects, male 
and female 
Pregnant (summer) 
21.9±10.73nmol/l 
Newborn (summer) 
16.72±4.99nmol/l 
Health 
personal(summer-
winter) 
17.98±7.98nmol/l 
7.98±3.49nmol/l 
 
 Goswami 
(60) 
2000 
India  Hospital-based, 
case-control 
Children aged 
2-60 months, 
cases-ARTI, 
control-healthy 
 95% for cases 
61% for control 
25(OH)D less than 
50nmol/l  
Wayse at al. 
(61) 
2003 
Nepal _ Data from 
population based 
trial 
Pregnant 
women, first 
trimester 
_ 16,4%-4,3%-7.1%-
24,7% (from spring 
to winter) 
25(OH)D<25nmol/l 
Jiang  at 
al.(51) 
2005 
India 
Delhi 
28
0
N Cross-sectional Schoolchildren 
10-18 years, 
LSES/USES 
LSES 
10.4±0.4ng/ml 
USES 
13.7±0.4ng/ml 
35.7% 
25(OH)D less than 
9ng/ml 
Marwaha 
(54) 
2005 
India 26,8
0 
N Cross-sectional Pregnant 
women and 
newborns 
14.09±9.5ng/ml-for 
women 
8.4±5.7ng/ml-for 
cord blood 
 
_ Sachan at 
al.(53) 
2005 
India, Delhi 28,37
0
N Cross-sectional Healthy school 
girls, 6-18 years 
LSES/USES 
LSES 
34.61±17.43nmol/l 
USES 
29.38±12.69nmol/l 
_ Puri and 
Marwaha at 
al.(55) 
2007 
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India 26
0
N Cross-sectional Pregnant 
women, 
adolescent girls 
(rural) 
_ 88.6%for girls 
74% for women 
25(OH)D<50nmol/l 
Sahu et al. 
(56) 
2009 
India, Delhi  Cross-sectional Middle-income 
male and 
female, 15-60 
years 
17.5±10.2 nmol/l 87% 
Less than 25 nmol/l 
Goswami 
(62) 
2009 
India, Delhi  Prospective-
cohort 
Term exclusive 
breastfeed  
Infants at 10weeks 
11.55±7.17ng/ml 
At 6 months 
16.96±133.33ng/ml 
Mothers 
8.89±5.97ng/ml 
 
 Agarwal at 
al. (58) 
2010 
 
Bangladesh
, north-
eastern 
part 
 Case-control Children aged 
1-23 months, 
cases-ARTI, 
control-healthy 
Cases 
29±17.2nmol/l 
Control 
39.1±9.4nmol/l 
 Roth at al. 
(23) 
2010 
India  Cross-sectional Pregnant 
women and 
breastfeed infant 
_ 96.3% of women, 
98.8% of infants 
25(OH)D less than 
50nmol/l 
Marwaha 
(57) 
2011 
Nepal 28
0 
N Cross-sectional Alcohol-use 
disorder patient 
43.9%±20 nmol/l 64% 
25(OH)D<50nmol/l 
Neupane at 
al. (52) 
2013 
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1.2 Rationale for the study 
 
 This study is emerged on the following basis of  
- Scientific gap 
Despite, there are several strong reasons to anticipate the high prevalence of vitamin D 
deficiency among children in rural Nepal, there is a little scientific research in this 
area. 
-  Child Health perspective  
The current appreciation of vitamin D’s importance for child health and understanding 
that deficiency may cause not only rickets but also contribute to the magnitude of 
childhood illness and have serious implication for future life. 
Thereby all these data lifted up the importance of identifying vitamin D status among 
children in Nepal. 
 
1.3 Hypothesis 
 
We hypothesized that despite of living in low latitude the magnitude of vitamin D deficiency 
and insufficiency among children at rural Nepal is high.  
Hypothesis for the purposed research was based on several findings from the literature 
review. In fact, there are available data that indicates high prevalence of vitamin D deficiency 
among population in South Asian region.  
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1.4 Objectives 
 
General objective: To assess the vitamin D status and contributing factors among children 
between1 to 5 years old in Nepal.  
 
Specific objectives 
1. To quantify the level of 25-hydroxivitamin D3 and D2 among children from 1 to 5 
years of old in a target setting. 
 
2. To measure the prevalence of vitamin D deficiency and insufficiency among study 
population.  
 
 
3.  To calculate Calcium intake from milk products among study population. 
 
4. To explore possible associations between vitamin D status and socio-demographic 
variables. 
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1.5  Introduction to study area 
1.5.1 Geographical features 
Nepal lies between latitude 26
0
-31
0
 N and longitudes 80
0
-89
0
 E in southern part of Asia and 
boarders with China in north and Indian in south. The altitude range is from 70 m above sea 
level to 8,850 m (Mountain Everest).   
   
                                                   
     
Figure 2: map of Nepal (63)                                
Nepal is landlocked country with total area of 147, 187 sq km and consists of three 
physiographic belts: Terai, Central Hill region, Mountain in the north. This separation 
correlated with the altitude range, from 70 to 1000 metres for Terai area, 800-4000 metres for 
Hill belts, and Great Himalayan Range for the Mountain belt (63).  
 
 
 
 
 
 
 
29 
1.5.2 Climate 
Nepal’s climate varies from the tropical to arctic due to enormous ranges in altitude. Terain 
belt characterises with tropical summer and mild winter, in the Mountains climate changes 
towards cool and above altitude 3 500 metres it is actually arctic climate with severe winter. 
As concerns seasons, in general about of 80% of annual rainfall is during monsoon period 
from June to September when the weather is hot and humid. The average temperature   in 
Kathmandu Valley during that period ranges from the min 19
0
 C to the max 29
0
 C; and from 
October to June is dry and cool season with temperature ranges from +2
0
 C during winter 
months to 30
0
 C for spring. Nepal has over 300 sunny days a year, with the average 8 sunlight 
hours per day from March to October (63). 
1.5.3 Economy and society 
As regards, the administration, Nepal is divided and subdivided into regions, zones, districts 
and Village Development Comities (VDC) respectively. Nepal has total population of 30, 430 
267, the majority lives in rural areas 81%, in general 25.2 % of population lives below the 
poverty line. For the 75% of population the main employment is agricultural field. At the 
same time, GDP per capita is 1300 USD $ (for comparison in Norway it is 55,300 USD $). 
The vast majority of population are Hindu 80.6%, the rest is Buddhist, Muslim, Kirant and 
others are 10.7%, 4.2%, 3.2%, 0.9% respectively. The literacy rate   is 60.3% measured as 
percentage of total population over 15 years that can read and write (64).   
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1.5.4 Health profile  
The infrastructure of health system in Nepal is based on the administrative pattern of country.  
Primary level: Sub Health Post, Health Post, Primary Health Care Centre; Secondary level: 
District Hospital, Zonal and Regional Hospitals; Tertiary level: Central and Teaching 
Hospitals (63). Nevertheless the coverage of health care system is low, and the majority of 
people in rural areas remain deprived of advanced health care facilities. This situation is 
aggravated with underdeveloped traffic and public transport system (64).  
Table below describes some public health indicators, as comparison data from Norway are 
available. 
Table 6: Public health indicators
*
  
Indicators Nepal                                  Norway 
Life expectancy M/F 65,26/ 67,82                              79/ 83 
Fertility rate 2.36                                              1.77 
Maternal mortality 170/100 000                              7/100 000 
Under five MR 50/ 1000                                      3/ 1000 
 
Underweight children (under the 
age of 5 years) 
29.1 % 
Prevalence of TB 238/ 100 000                               8/ 100 000 
*From CIA factbook. Mortality Ratio from WHO(65) . 
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2. Chapter II, Methodology 
2.1 Overview 
A community based cross-sectional study was conducted in Ugrachandi Nala Village 
Development Committee of Nepal. The data collection took place between the 29
th
 of 
September and the 10
th
 of November. 
For the vitamin D assessment, blood samples have been collected using dried blood spot 
technique. The bio samples have been transported from Nepal to Norway for the farther 
analysis at the “Vitas” laboratory.  Information regarding calcium intake and background 
variables has been collected through structured questionnaire. 
2.2 Study design 
 
Study design was chosen based on the objectives. The main objective of study was to assess 
the vitamin D status and contributing factors among children between1 to 5 years old in 
Nepal. In other words, we wanted to know the prevalence of vitamin D insufficiency and 
deficiency among target population. For that aim it was reasonable to conduct a cross- 
sectional study with further quantitative analysis of the collected data. 
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2.3 Sampling 
2.3.1 Study area and population 
Ugrachandi Nala VDC belongs to Bagamati zone and is situated within Kathmandu Valley. It 
consists of nine wards (villages), with total population of 6327. 
The choice of study site was based on several reasons. First of all due to geographic 
coordinates, the VDC is located at the latitude 27, 39
0
 N and altitude 1400m.  It has been 
shown by Holick at al that the synthesis of vitamin D decrease significantly during winter 
months even at latitude 27
0
N if altitude below 3400m (43). Secondly, VDC is diverse in many 
ways; it consists of very remote, inaccessible wards as well as wards that are close to the 
nearest city Bonepa. Also, the population of the VDC belongs to different ethnic groups and 
socio-economic layers. All these factors make the Ugrachandi Nala VDC appropriate area for 
the current study. 
 
Figure 3: Ugrachandi Nala –study area 
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2.3.2 Sample size calculation 
 
The sample size has been calculated based on the prevalence of vitamin D deficiency 
recorded in the rural Nepal at the latitude 26,96
0
N among pregnant women during first 
trimesters, which has been measured during winter months (51). The stated prevalence is 
lowest among those that have been identified during literature review in the region.  
For sample size calculation we used the following formula 
N = Z
2
 P (1-P)/ d
2
, 
Where: Z for 95% of CI is 1, 96; d is precision = 0, 05; P is expected prevalence 24, 4% (0, 
24); 
Based on the calculation above we have to include 280 children between 1- 5 years in order to 
show that vitamin D deficiency is prevalent in that area (24.4 %).  
2.3.3 Inclusion criteria 
 All children between 1 to 5 years old in the chosen villages were eligible.   
2.3.4. Exclusion criteria 
 
 Child was excluded from the study if meets at least one of the following criteria: 
 Known metabolic bone disease or chronic disease known to be associated with bone 
abnormalities (inflammatory bowel disease, celiac disease).  
 Current medication is likely to interfere with vitamin D metabolism (Phenytoin, 
Phenobarbital, Carbamazepin, Izoniazid, Theophylline, Rifampin). 
  Parents Inability to provide informed consent or comply with study protocol.  
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2.3.5 Sampling study subjects 
 
So far as there is not available demographic registry in Nepal. We decided to make list of 
children from 1 to 5 years of old based on the available records. As a base for sampling we 
used records from Nepal’s national vitamin A supplementation program for children aged 6 to 
59 months with coverage of 90.4% as for 2011 (64) available at local health post. Out of 
available records we created numbered list of all 411 children aged 12-60 months living at 
VDC. By using online randomizer, a set of 320 unique sorted numbers was generated with 
range from 1 to 411 (representing the children assigned numbers). Subjects were selected 
randomly according to the produced list of numbers. Community Health Volunteers women 
were requested to identify selected children and invite guardians for participation in the study. 
We selected 320 children in order to achieve sample size of 280 subjects.   
2.4 Research group at field work 
 Research assistant, with bachelor degree in nursing and experience in   research field 
work; 
 Nurses, with 4 years’ experience working in child health hospital; one permanent and 
one substitute nurse; 
 We were cooperating with community health volunteer’s women from each ward 
during recruitment stage.  
 Principal investigator with 3 years of experience working in child health clinic as a 
staff paediatrician; 
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2.5 Training for research assistant and nurses 
 
The vitamin D physiology, determinants for the development of deficiency and importance it 
for child health has been presented on the lecture for the research assistant and nurses. Also, it 
was explained objectives of the study and information stated in the consent form and how to 
treat participants. 
Additionally, research assistant was taught, how to conduct interview, all points in the 
questionnaire have been discussed separately, with possible answers, and how to record them. 
The procedure of data entry from questionnaire to EpiData has been explained in later stage. 
The importance of preserving confidentiality has been outlined.  
Nurses has been taught regarding procedure of taking anthropometric measurements, 
according to WHO Training course on Child Grow Assessment (66), she was explained how 
to do it correctly and record accurately. Also, collection of blood spots for the vitamin D 
analysis was described, through watching educational film and leaflets, provided by Vitas 
laboratory in Norway.    All stages of dry blood spots collection technique have been 
emphasized. 
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2.6 Pilot study 
 
Pilot study has been conducted among first 10 households at ward number 3.The aims of pilot 
study were the following: To pre -test the questionnaire, make sure that each question is 
understandable and the possible answers are mutual exclusive. To quantify time needed for 
one interview and to calculate the maximum number of participants per day. To identify the 
general flow of data collection,  
Based on the result the following changes have been made: 
 The question regarding diet (mother were required describe what would typically child 
have for breakfast lunch or dinner), we found that all families provide the same 
traditional meal for children from 1-5 years of old, so the question was considered not 
informative. 
 The question related to the assessment of child’s gross motor and teething milestones 
was omitted, because majority of parents were not able to recall information 
accurately.  
 The question regarding child illness (the mothers were requested  to specify the 
severity of ARTI during the last 4 weeks, if any) we found that it is not clear enough, 
so we modified it with possible one or more options (child was playing/ lying in the 
bed/ refused the meal or breastfeeding/ breathing difficulties/ did you call health 
personnel)  
 At first, according to study protocol it was planned to take blood samples by pricking 
the children’s heel if they are smaller than 2 years of old, and for older ones from the 
finger. But we observed, most of the children do not were appropriate shoes or socks 
what might cause the contamination of wound after puncturing. So, it was decided to 
take blood samples by pricking the tips of finger for all age groups.    
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 Initially was planned to conduct data collection from household to household, 
however during pre-testament it became clear that it is not convenient. The reasons 
were that it was not possible to find firm floor and straight wall for adjustment of 
anthropometric equipment, or enough space to work at most of the households. Also, 
it was difficult to find child and mother at the same time at home. So, we decided to 
conduct data collection in one or two places for each ward, with the convenient 
location for the local community and suitable for the research group. 
2.7 Data collection 
2.7.1 Recruitment 
The community healths volunteers (CHV) were informed about the objectives of the study, 
and were asked voluntarily cooperate with the research group. 
Ten CHV’ women from nine wards have been contacted to identify 320 selected children. 316 
children have been identified. Out of 320 children, 11 have been moved permanently, 9 
children were away, guardians of 16 children refused; as a result the 280 children have been 
recruited for the present study.  Additionally, 13 children out of randomly created sample 
were included to the study by the request of the guardians. 
 
 The place and date for the data collection has been discussed priory with the community 
leaders of each wards based on the harvesting schedule in the village and daily routine of the 
community. The invitation to the guardians of chosen children has been send by the CHV via 
phone call or door to door visit two days before of assigned date for the each ward.   
 Consequently, the main data collection took place during 11 days at different public or 
private places, such as schools outside of working hours or community health worker’s 
household. For those who were not being able to participate in regular day, we arranged 
household visit, by their request.  
 
 
 
38 
2.7.2 Data collection flow 
 
In general, data collection was organised in three stages.  The objective of the study and data 
collection was explained for the guardian. After informed consent form has been signed, the 
research assistant fulfilled form with personal information of the child. Consequently each 
child has been encoded with the random identification (ID) number. Only code number was 
used during study, and the key between code and candidates’ ID was kept separately to ensure 
confidentiality.  The form with personal information, questionnaire and card for blood sample 
has been coded with the same number for each child. We have used prepared stickers with the 
same ID numbers on the group of three labels for each child to avoid confusion. The unique 
ID numbers has been generated randomly by software and consisted of two capital letters and 
three figures. 
 At first, mother was interviewed according to structured questionnaire with research 
assistant. At second, anthropometrics measurement of the child has been taken by nurse with 
the help of mother. At third, collection of blood samples from the child.  
At the end of each data collection day, all forms that have been used were tallied with sample 
cards by similarities of identification number. 
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Figure 4: Interview , during data collection at ward № 8, public school 
2.7.3 Interview 
 
For background variables and food frequency assessment we have used structured questions. 
The questionnaire were prepared in English and translated into Nepali language. The general 
structure and the question’s number remained as in the original version. The questionnaire 
consisted of the following sections: household information; infant feeding history; child’s 
diet, consumption of milk’s products; immunization history; child’s development; sun 
exposure; The interviewer was reading the  questions and recoding answers. At the end of 
interview, questionnaire was checked for the any missing data or inconsistency.    For the 
question required understanding of measurement scales (millilitre of milk) we demonstrated 
the common kitchen bowl, which normally used in the population for the child’s feeding. 
 Milk products intake was calculated by multiplying the amount per serving and the 
frequencies of consumptions for each type of milk product. Calcium intake was computed by 
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multiplying the calcium content of the specific type of milk by the daily consumed amount. 
Total calcium intake from milk products was calculated by summing the calcium intake from 
different milk products for each child. Calcium value in milk products were obtained from 
USDA National Nutrient Database for Standard Reference (67) . All calculation related to 
Calcium consumption has been done during data analysis stage, during data collection just 
consumed amount of products has been recorded.  
2.7.4 Anthropometric measurement 
 
Anthropometric measurement were performed according to WHO Training course on Child 
Grow Assessment (66). Weight has been measuring with digital weight scale made by 
Microlife Company in Swiss, certified for ISO 9001 accurate to 100g. Height has been 
measuring by wall stadiometer made by Bio-Plus 200cm, Model 265M/1013522.  
Place for the anthropometric measurement has been chosen according to the following 
criteria: sturdy, flat surface for the weight scale and strong, straight wall to hang stature meter. 
The measurement were taken according to WHO Training course on Child Grow Assessment 
(66). The clothing on the child has been minimized; shoes have been taken off before the 
measurement. Each child has been weighed twice; we recorded results of both measurements 
if they were different, afterwards the mathematically average were calculated. For the 
children under 24 months or with difficulties to stand alone on the scale we weighed mother 
and child simultaneously and calculated child’s weight mathematically based on the two 
different measurements, by subtracting weight of mother from the weight of mother weighted 
with child. Height was measured by stature metre hanged on the wall to the nearest 1 mm.  
During measurement child was requested to look straight ahead at the mother (standing in 
front of him/her). Mother was asked to assist by the fixing child’s shins and knees. The nurse 
made sure that the shoulders are level at the same time fixed the chin and performed 
measurement.  For a few cases when child was scared and extremely uncomfortable the height 
has not been measured. The result of weight and height measurements has been recorded in 
the questionnaire of each participant.  
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2.7.5 Assessment of nutritional status (has been done during data analysis) 
The nutrition status of the children was determined by comparing measurements of weight for 
height, weight for age and height for age to the WHO reference standards for wasting, 
underweight, and stunting indicators, respectively (68).    
1. weight-for-height (WFH) – wasting indicator (acute or recent malnutrition)  
2. weight-for-age (WFA) – underweight indicator (acute or chronic malnutrition) 
3. height-for-age (HFA) – stunting indicator (chronic or long-standing malnutrition) 
Global acute malnutrition (wasting) is defined as <-2 z scores weight-for-height and/or 
oedema. Severe acute malnutrition is defined as <-3z scores weight-for-height and/or oedema. 
Underweight is defined as <-2z scores weight-for-age while severe underweight is defined as 
<-3z scores weight-for-age. Chronic malnutrition (stunting) is defined as <-2 z scores height-
for-age while severe chronic malnutrition is defined as <-3z scores height-for-age. 
2.7.6 Assessment of vitamin D level (collection of blood samples) 
For the vitamin D assessment we have used whole dried blood spots technique with liquid 
chromatography- tandem mass spectrometry method. The LC-MS/ MS from DBS method 
was internally validate, it was chosen as a less invasive and convenient to use with paediatric 
groups in the field research. The vitamin D kits were provided by Vitas laboratory in Norway. 
Each kit consisted of paper card with marked circles for the blood absorption, foil zip bag 
with sachet of drying agent, swabs with alcohol, dry sterile swabs, single use lancet and 
plaster.  
The nurse made sure that the child’s hands were washed with soap and dried (soap, clean 
water and towel have been provided).Consequently, the card was opened and child’s fingertip 
was wiped with alcohol swabs. Fingertip was punctured by single use safety lancet. After the 
prick, the first blood’s drop was removed with sterile swabs and the next droops were applied 
directly on the sampling paper (card) with pre-marked three circles, one-two drop for one 
circle. 
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.
 
Figure 5: Nurse takes blood samples, ward №4 
2.8 Data management 
2.8.1 Storage and Transportation of blood samples 
The cards were dried during 2 hours in the prepared trays and covered with medical gauze; 
afterwards sample cards were stored in low gas –permeable zip lock bag with desiccant 
packages. During first 7-10 days sample cards have been kept in a room temperature.  
Consequently the samples were transported to the Bhactapur Cancer Hospital in order to be 
kept in the refrigerator under the + 4C
0 
t with permanent electricity supply until the end of the 
data collection. 
 At the end of field work bio samples were divided into two parcels and shifted to the Vitas 
laboratory in Norway by DHL Express. The samples were sent in two separate parcels with 
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two day differences processing from the security reasons, and were received in three days 
each. The levels of 25(OH) D3 and 25(OH) D2 were quantified separately by using liquid – 
chromatography – tandem mass spectrometry (LC-MS/ MS) from dry blood spots. 
 
2.8.2 Data handling and entry 
 
At the end of each data collection day, all forms that had been used were tallied with sample 
cards by similarities of ID number. The bio materials were stored as it is described above. The 
questionnaire and personal information form were safely kept at the locked room. 
Double data entry was done during two weeks after the data collection stage had been 
completed. The data was entered to EpiData by principal investigator and research assistant. 
Two types of file were created, one for personal identification information another for 
questionnaire. The random ID number was marked as key variable for both files. The missing 
data was recorded as 99 and not applicable one as 88. Consequently, two sets of files had been 
compared, whether data in two different fillies is the same, and all recorded discrepancies that 
occurred due to mistyping were corrected. When result from vitamin D test had been 
available, it was entered   based on the key variable. 
The questionnaires were sent by post, all personal information and consent forms were 
brought by hand carriage to Norway. Then, all set of data were kept at the locked cabinet at 
the Department of Community Medicine.  
2.8.3 Coding variables and preparing data for analysis 
 
The data were transformed from EpiData into PAWS, version 20. In general, we had 45 
variables, the majority of our variables were categorical, when fixed number allocated to the 
specific answer. Additionally, we created some new categorical variables from the continuous 
numerical, such as ‘monthly household income’ It was done to identify three levels of 
possible salary: low 0-14999 NR, middle 15000-39999 NR, and high 40000 NR or higher; 
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Consequently the data was screened for the missing data by using frequencies for categorical 
variables and descriptive for continuous numerical; outliers and normal distribution was 
assessed through using descriptive statistic and creating box plots and histogram;   
2.9 Data Analysis 
 
Statistical analysis of the data was performed by using PASW software (version 20, SPSS 
IBM Corporation, USA). WHO Anthro software (version 3.2.2), was used to evaluate gender 
specific growth indicators in relation to WHO standards (68).  Standing height for children 
younger than 24 months was equalized to the recumbent length by adding 0.7 cm. according 
to WHO Anthro software’s guidelines.  Data from descriptive statistic were presented as 
mean scores and standard deviation. To compare the mean scores of continuous variables 
between two different groups of categorical variables we used independent sample t-test (two-
tailed). One way analysis of variance was performed to explore association between vitamin 
D concentrations with the categorical explanatory variables. For unequal variances the non-
parametric test has been used (Kruskal- Wallis). Results have been considered statistically 
significant with p value below 0.05. 
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 2.10 Timetable 
 
Protocol writing and research planning – April- June, 2012 
Time allocated for field work 3 months- September- November, 2012 
 Meeting with CHV and community leaders -1 week 
 Translation of questionnaire into Nepali language – 1 week 
 Training for research assistant and nurses - 1 week 
 Pilot study 1 week 
 Changes in the questionnaire and discussion with research team – 1 week 
 Data collection – 6 weeks 
 Data entry – 2 weeks 
 Miscellaneous activities – 1 week 
Laboratory analysis of bio material –December-June, 2013 
Thesis writing – February- July, 2013 
Paper submission – November, 2013  
Thesis submission- November, 2013 
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2.11 Ethical issues  
 
The study was approved by the Nepal Health Research Council and Regional Committee for 
Medical and Health Research in Norway.  Informed written or witness consent was obtained 
from the guardians of all participants. Witness consent was acquired when guardian had a 
decision making capacity but cannot read or write due to illiteracy.  Witness was an adult 
from the same community who was not a member of study team.   
On the early stage of study planning we have identified several vulnerabilities of our study 
subjects. One of factors that make the general population vulnerable is poverty and high 
illiteracy rate. Another aspect was that the study units are children, depended upon their 
guardians. Moreover there were imbalance of power between population and research group, 
due to our cooperation with community health volunteers’ women for the recruitment 
procedures. 
Proceeding from the factors mentioned above we assumed the following measurement to 
ensure that the study conducted according to the international ethical guidelines for research 
involving human subjects as it is stated in the Declaration of Helsinki.   
 The inform consent form was read by research assistant, and additionally explained in 
a simple manner, the possibility to withdraw child from the study at any stage of 
research work was emphasised.  
 During the data collection, interviewer took into the consideration that the interview 
take place in the public place with other people around. So, before asking sensitive 
question, the possibility to omit the question was emphasised. 
  As regards, the blood collecting procedures. In the cases when child was extremely 
uncomfortable and expressed it with cry, we made sure that mother still want to take 
part in the study. The opportunities of withdrawal child at all or participation in the 
other day was explained. Additionally, we prepared small gift for each child to 
compensate uncomfortable feeling from the painful procedures. The gift package 
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consisted of school supplies and personal hygiene items, the cost of each pack was 
around 100 Nepalese Rupees, we thought that this small amount would not be 
considered as an inductive method (1 Nepalese Rupees as of April 1, 2013 = 0.107 
NOK) but will give pleasant feeling to the child.  
 We were cooperating with community health volunteers’ women during recruitment 
procedures. As a matter of fact it made possible to keep random sampling. However, 
we undertook all cautions to avoid misunderstanding from the local population 
regarding involvement of CHV. The CHV were instructed about voluntarily bases of 
study, and what should include message with invitation towards participants. Before 
giving agreement to take part in the study participants were explained that there is not 
any association between current study and their relationship with CHV. In other 
words, it was emphasised that they are free to make decision whether to take part or 
not and it will not have influence on any farther services that they might need from 
CHV. 
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 2.12 Methodological consideration 
 
Study was designed as a community based cross-sectional. Cross-sectional study is ideal for 
describing of variables’ magnitude in our case the prevalence of vitamin deficiency and 
insufficiency, as well as to explore the association between vitamin D status and background 
variables. However, the cross sectional design estimate outcomes and exposure in the same 
time, consequently the chosen methodology does not allow us to look into causality of 
vitamin D deficiency or to clarify which factors contribute more to the development of 
vitamin D deficiency as it do in a case- control design. Another limitation of chosen 
methodology is inability to gain knowledge about consequences of vitamin D deficiency 
through the making follow up as it is possible in cohort study.  
Nevertheless, the cross-sectional design meets objectives of study. Also, based on the 
literature review, we can say that the vast majorities of relevant studies that make a 
framework for our purposed research had a cross – sectional design. 
 
2.12.1 Strength and weakness that effect on internal validity 
 
Strength and limitation discussed on the light of assessing quality criteria for prevalence 
study. Internal validity can be affected with introduction of bias from sampling and recruiting 
participants to collecting data and performing measurement. In our study we identified 
selection and information biases, those was not possible to avoid due to particularities of 
research setting.  
Sample size and data collection period 
Sample size was calculated based on the high precision d equal to 0.05, it reduces the width of 
CI to 10%, and we reached whole sample size as it was planned. Although in order to 
calculate sample size we had used lowest prevalence recorded during winter months from the 
South Asian region that was identified during literature review. But, due to framework of 
master program, it was not visible to conduct field work during winter months; our data 
collection was done from 29
th
 of September to 10
th
 of November.  
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Sampling method and selection bias 
For the drawing sample from population the randomization was applied. In other words all 
children got the equal chances to be selected for the study. Although, due to the absence of 
demographic data in the region, we have had to create our own databases from the records of 
vitamin A supplementation program, available at VDC health post. So, children those for 
some reasons did not get vitamin A during last 6 months were not included in our databases, 
and consequently did not get chance to be selected for the current study. This kind of selection 
bias may result that our sample more representative for those who has better access to health 
care programs than for general population in total.  
 
Response rate 
In the current study we got respond rate 87.5%, which is considered adequate for the 
prevalence study. Nevertheless, we do not have information on non-respondents. It might be 
that people who did not give consent are different in their lifestyle, health seeking behaviour 
or in other ways from the participants.  
 
Measurements with valid instruments 
Before actual data collection, pilot study was conducted to pre-test the questionnaire, and the 
necessary changes were done. Nevertheless, there were other limitations of the study:  
Information was gained through self-reported questionnaire with help of interviewer and it 
may affect validity of data regarding child’s health or nutrition. It is possible that parents 
might over report use of milk products or completeness of immunization history due to 
socially acceptable meanings of what is best for the child. Also, we observed that parents tend 
to under report information on respiratory infection. We assumed that it had happened due to 
culturally different determination of respiratory infection. It would be more advisable to 
conduct small qualitative study beforehand with aim of exploring the meaning of respiratory 
infection in the local community and based on that design questionnaire. Also, the question 
regarding sun exposure was not enough detailed, it did not clarify time of being outside in the 
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relation of noon. It is important due to the effect on the vitamin D production in the skin under 
the impact of UVB.  
Additionally, it was not visible to allocate separate place for the interview. Which may have 
resulted response information bias since, participants might be shy to give answer on the 
question regarding income level or drinking problem in the family. Another source of 
information bias was language barrier, it was not possible to ensure that research assistant was 
asking question and recording answers in the same manner in the relation to all participants as 
we assumed.  
Another aspect that affects the quality of data is approximation in the age of children. 
Nepalese people did not register children immediately after birth, situation with clarifying an 
age was aggravated because of differences in calendar year between lunisolar Hindu calendar 
officially used in Nepal and western Gregorian one. So, we register age of child based on the 
mother’s claiming, but we accept deviation in 6-12 months. Yet another limitation, for weight 
and height measurements we used equipment that were not standardised for establishing of 
anthropometric databases. 
 
Assessment of vitamin D status 
For the assessment of vitamin D status we have used dried blood spot sampling technique 
with farther analysis of 25(OH)D by using  LC-MS/MS methods. LC-MS/MS methods  
allows to measure 25(OH)D2 and 25(OH)D3 separately and  is considered as a gold standard 
for the assessment of vitamin D level(35).As regarding use of dried blood spot techniques for 
the blood collection it has been shown good agreement with the serum level (39) and was 
internally validated in the laboratory. DBS sampling method allowed us to avoid 
venepuncture for children and consequently to follow community based study design and to 
achieve whole sample size. Blood samples were collected, stored and shipped according to 
recognized standards.  
It might be considered as limitation the absence of data on the level of calcium, phosphorus 
and alkaline phosphatase from our study population. Although, these indicators deviate during 
severe vitamin D deficiency and are more relevant to the assessment of bone metabolism and 
(40).  However, simple measurement of 25(OH)D reflects the objectives of our study to assess 
the vitamin D status of children.  
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2.12.2 Strength and weakness that effect on external validity  
 
High degree of external validity means that the result of the study can be applied to 
population from which it drawn. External validity is determined by the representativeness and 
homogenous of the group presented in the sample. In general, this study is unique in terms of 
study subjects and setting, it was designed as a population based so it has better 
representativeness than those that were designed as a hospital or school based. Although, as 
we discussed above, children in our study represent those who has some access to health care 
program in rural area of Nepal at latitude 27,39
0
 N. However, thinking about 
representativeness, we should take into consideration that Nepal is country with tremendous 
diversity of altitude. In fact, altitude effects on the vitamin D production through the whole 
year. Consequently, we can conclude that result of present study could be generalized in 
certain extend with respects to geographical coordinates and study population.  
 
2.13 Disseminations of Results 
 
Present research work was conducted as a part of M.Phil. Program in International 
Community Health, consequently thesis was submitted to the Department of Community 
Medicine at the University of Oslo. The thesis will be available online on the DUO system at 
the University Library. Besides, an article was written based on the data from the field work, 
co-authored with supervisor, co supervisor and collaborative laboratory. Article was 
submitted to the British Journal of Nutrition. 
Copy of thesis and article after publication will be send to NHRC, as we claimed in the 
application form. The results of vitamin D tests will be available for guardians of all children 
as it was stated in the protocol. It will be send electronically to research assistant, who will 
make it available at the local health post.  
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Declaration of Consent 
We cordially invite you to participate in a research project entitled “The vitamin D 
status among children 1 to 5 years old in Urgachandi Nala Village Development Committee 
of Nepal”.  
The main objective of the project is to investigate the prevalence of vitamin D 
deficiency and insufficiency among children 1 to 5 years old in rural Nepal. 
Vitamin D among other nutrients is important for the child growth and development. 
This study is necessary to identify the status of your child in this term, and useful for future 
intervention also. 
In case you agree to give permission for participation of your child, child will be test for 
vitamin D level free of charge. Besides, we will send the results of the test to the local health 
post which can be collect when available, if it is found that your child has any insufficiency, 
the recommendation for the supplementary therapy will be given.  In addition, the information 
gathered in the study will provide the foundation to improvements in the preventive strategies 
of vitamin D deficiency among children, resulting in reduced morbidity. 
The examinations and investigations that will be carried out in the study (blood 
drawing to assess vitamin D level; questionnaires to assess socio-economic, and health data; 
anthropometric measurement) are not life-threatening. We shall ask you some questions that 
may take about 15-20 minutes. We will take measurement from child (weight and high). We 
would like to collect about 1ml (a little in Nepali) of blood using a needle prick on the child’s 
finger or heel, a common procedure and does not pose a serious danger. Blood samples will 
be collected by qualified and trained health personnel, and precautions will be made to 
prevent infections and / or injuries. The samples and data that are registered about you will 
only be used in accordance with the purpose of the study as described above. 
All information obtained from you will be strictly confidential. Participation is 
voluntary and you are free to refuse to participate in any procedure or to refuse to answer any 
question at any time without prejudice or consequences for further treatment. You are also 
free to withdraw your consent from the study at any moment. In this case, the blood sample of 
your child will be destroyed and the information you have provided will be deleted from the 
register. In addition, the research investigators will answer any of your questions about the 
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research procedures, your rights as a subject and research-related injuries. A copy of this 
consent form can be given to you if you so request. 
 
Note: If you have any questions or complaints about the informed consent process or policy, 
please contact the investigators.  
 Based on the information provided, if you want to join the study, please sign below: 
 
________________________    _______________________ 
Place and date                                                             Signature of the Participant 
 
________________________   Signature of the Witness (In case the participant cannot sign) 
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Questionnaire for research project ‘The vitamin D status among children from 1 to 5 
years old in Ugrachandi Nala Village Development Committee of Nepal' 
DATE                                  <dd/mm/yyyy> 
 
RANDOM ID  
Respondent relation to the child _____________________ 
 
Household information 
Q001       Ward _______________ 
Q002       Religion_______________ 
Q003       Ethnicity: __________ 
Q004      Number of persons in the household: ___________ 
Q005       Number of children from 1 to 5 years old in the household ___________ 
Q006       Sex (of participants/child) M / F 
Q007       Date of the birth of child/age in months___________ 
Q008       Father's occupation ____________________ 
Q009       Mother's occupation ____________________ 
Q010       Type of the housing __________________ 
Q011       For how many months per year does your farming feed the family? __________ 
Q012     Monthly household income (salary, sale of crops, etc. NRS)  
_____________________ 
 
 Infant feeding 
Q013    Has (child's name) ever been breastfed? Yes / No    
Q014    If yes, Is the child still being breastfed now? Yes / No 
Q015 If yes, how often do you breastfeed your child now?  
times /day_____________  
Q016       If not breastfed anymore, how old was the child when you stopped breast-feeding 
completely? ____________ 
Q017       How old was your child when you gave him/her first solid food (porridge (LITO / 
JAULO))___________________ 
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Vitamin and mineral supplementation 
Q018       Did you (mother) take any vitamin or mineral supplementation during pregnancy?   
Yes / No / Do not remember 
            (for those who breastfeed child now) 
Q019        If Yes, please specify when, what type how often and how long?  During ______ 
trimester, during _______ months 
       
 
Q020        Do you (mother) take any vitamin or mineral supplementation during 
breastfeeding? Yes / No / Do not remember  
(for those who breastfeed child now) 
Q021       If Yes, please specify when, what type how often and how long?  During last 
________ weeks/ months  
      
If yes, please specify 
Type of supplementation: 
 
times/week 
1    2     3     4    5    6   7 
times/day                   
1        2         3    
Amount per time    
 
1 tab   2 tablet 
 
Q022        Does your child take vitamin and/or mineral supplements now?  Yes /No 
Q023       If yes, please specify type of supplementation: 
Have been taking during ____________________ 
          
If yes, please specify 
Type of supplementation: 
 
times/week 
1    2     3     4    5    6   7 
times/day                   
1        2         3        
Amount per time    
 
1 tab   2 tablet 
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If yes, please specify 
Type of supplementation: 
 
times/week 
1    2     3     4    5    6   7 
times/day                   
1        2         3    
Amount per time    
 
1 tab   2 tablet 
3ml       5ml 
 
Q024 Immunization history (Information from health post's 
records)_______________________________ 
 Child's development 
Q025 Please list at what AGE (month) that your child was with respect to the following 
25.1        Sat up on their own  
25.2        Started crawling  
25.3        Stood with support  
25.4        Stood on their own  
25.5        Started walking  
25.6        Walked up/down stairs  
25.7        Started teething  
 
Past and current health concerns, Please, indicate and give details   
Q026       Childhood illnesses Yes/ No 
            If yes, please specify_________________________ 
Q027       Any chronic illness or disability Yes/ No 
            If yes, please specify_______________________ 
Q028        Accident Yes/ No 
            if yes, please specify______________________ 
Q029       Major fall or injuries Yes/ No 
            if yes, please specify______________________ 
Q030       Operation Yes/ No      If yes, please specify________________________ 
Q031       Hospitalization Yes/ No 
            If yes, please specify _______________________ 
Q032       Medication Yes/ No 
            If yes, please specify ______________________ 
 
Q033        Has child ever had convulsions without fever Yes/ No 
            If yes, please specify, how many time and when 
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________________________________________________________ 
Q034       Has child had diarrhoea in the last four weeks 
 Yes/ No 
            If yes, please specify how often and when was the last episode 
_____________________________________  
Q035       Has child had symptoms of acute respiratory tract infections during last four weeks 
Yes/ No 
            If yes, please specify how many times and how severe it 
was_________________________________________________ 
 He/she was playing 
 He/ she was lying in the bed  
 He/she refused the meal/ breastfeeding  
 Did she/he have breathing difficulties? Yes / No  
 Did you call for health person?        Yes/ No 
General information on Diet  
Q036 Please list what your child would typically have for: (question was deleted after pre-
testing ) 
  
Breakfast 
 
 
Lunch 
 
 
Dinner 
Snacks 
 
 
Q037 How many times does your child have egg during his/her meal 
__________________week (if never, leave it empty)  
Q038        Is any specific diet regime followed?  vegetarian / vegan / other 
_________________________________________________ 
Q039        Other information on his/her 
nutrition:______________________________________________________ 
 Q040 Type of milk 
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Type of milk Per day Per week Amount of milk usually consume per 
time? 
Standard  milk formula 5+  4    3   2  1 
 
 
1-3   4-6 
 
               
60   120   180       240 
A         B       C           D 
                       
Whole milk purchased in 
the market (packet milk) 
 
 
1-3   4-6 
               
 
                   
Cow milk  
 
1-3   4-6 
               
 
                   
Buffalo milk  
 
1-3   4-6 
               
 
                   
Goat’s milk  
 
1-3   4-6 
               
 
                   
Sour milk/yogurt   
 
1-3   4-6 
               
 
                   
 
Sun exposure 
Q041   How much time the child spends in the sun every day  
  < 15 minutes per day 
  15-30 minutes per day 
  more than 30 min- to 60 minutes per day 
  more than 1- 2 hours per day 
  > 2 hours per day 
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Q042    Describe, what does child wears normally outdoor?  
 Trousers      
 Short pan 
 T-shirt 
 Long sleeves shirt 
 Cap/ Hat  
Q043    Information on smoking  
       Does       anyone smoke in the home? Yes / No/ No answer 
        if yes please specify___________________________________ 
 
Q044 Information on alcohol consumption  
Does anybody in the family have drinking problems?   
 Yes / No/ No answer  
        If yes, Can you specify? _______________________________ 
 
Q045 Additional information___________________________________ 
_______________________________________________________________ 
 
Q046 High (cm)________________________ 
 
Q047 Weight (kg)_____________________ 
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Abstract 
Insufficiency of vitamin D, which plays a major role in the calcium and bone metabolism, is 
reported from populations worldwide. Its extra skeletal benefits are being identified, vitamin 
D is important in function of immune and cardiovascular systems. However, little is known 
about the vitamin D status among populations from developing country settings, particularly 
in children. We aimed to assess the vitamin D status and contributing factors among children 
between 1 to 5 years of age in rural Nepal at latitude 27.39
0 
N. A total of 280 children aged 
between 1 and 5 years were randomly selected from the records of vitamin A supplementation 
program and included in the study. Blood samples were collected using the dried blood spot 
technique. The level of serum 25-hydroxyvitamin D3 (25(OH) D3) and D2 (25(OH) D2) were 
measured in whole dried blood spots (DBS) by using liquid chromatography- tandem mass 
spectrometry analysis (LC-MS/MS). For the assessment of calcium intake and background 
variables we used structured questionnaire. Hypovitaminosis D, defined as a 25(OH)D3 level 
less than 50nmol/l was identified in 91.1% of children. There was no association between 
level of 25(OH) D3 and gender, socio-economic indicators, sun exposure or nutritional status. 
Vitamin D deficiency is common among children from 1-5 years of old living in rural Nepal. 
Keywords: Vitamin D deficiency, Dried blood spot, Child health, South Asia 
Abbreviation: liquid chromatography- tandem mass spectrometry (LC-MS/MS);  dried blood 
spots (DBS); 25-hydroxyvitamin D3 (25(OH)D3), 25-hydroxyvitamin D2 (25(OH)D2) 
 
 
 
 
 
 
 
 
 
69 
 
Vitamin D is a prohormone that plays an essential role in the mineralisation of bones 
(1)
. There 
are two ways for humans to meet requirement for vitamin D, the major amount is produced in 
the skin after exposure to sunlight and the rest is to be fulfilled through dietary sources. There 
are few foods that are naturally rich with vitamin D, although there are some fortified 
products available for consumption 
(2)
. Vitamin D deficiency leads to comprehensive failure 
in the mineralization of the bones and development of osteomalacia; for children when 
skeletal system is immature it manifests in the form of rickets 
(3)
.  Moreover, the role of 
vitamin D as a prohormone for the human health is reappraised 
(4-7)
. It has been suggested that  
maintaining vitamin D level on the normal ranges is not only essential for normal 
development and function of skeletal system but also may play important role in the 
prevention of autoimmune, neoplastic and cardiovascular diseases 
(8)
. There is growing 
evidence that vitamin D deficiency may contribute to the incidence and the severity of acute 
lower respiratory tract infections as well as progression of tuberculosis to its active form 
(9-12)
. 
The nuclear vitamin D receptor is presents in the majority of human’s tissues (8), and the most 
type of cells are able to transform vitamin D into the its active form 1,25-dihydroxyvitamin D 
(13)
. Hence, vitamin D regulates expression of more than 200 genes with transcription of 
various proteins. These proteins adjust cellular differentiation, proliferation and apoptosis 
with consequent effects on the function of many organs and systems 
(10, 14)
.  As a matter of 
fact, for paediatric groups of developing countries the potential modular effect of vitamin D 
on immune system and on risk of acquiring respiratory infections is more crucial and 
influential on public health indicators.   
Vitamin D insufficiency and deficiency are prevalent around the globe 
(15-17)
, it has 
been calculated that around 14% of the world population are vitamin D insufficient or  
deficient  
(6)
, even though the magnitude varies between age groups, gender and geographic 
region 
(15)
.  During recent years, numbers of studies have shown high prevalence of vitamin D 
deficiency among South Asian population 
(15, 18)
. Various reports 
(16, 17, 19)
 from India show 
that the average circulating vitamin D levels in adults ranges from 25nmol/l to 50nmol/l the 
same figures relevant to neonates and infants 
(20-22)
. The little is known about vitamin D status 
among population in Nepal. There is available data regarding vitamin D status of pregnant 
women during first trimester, author recorded seasonal variation of vitamin D deficiency from 
4.3% to 24.4 % with cut of level 25nmol/l 
(23)
. Another study conducted among alcohol-use-
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disorders inpatients recorded 64% of vitamin D deficiency defined as a vitamin D level less 
than 50 nmol/l 
(24)
.    
Despite the current appreciation of vitamin D’s importance for child health and 
understanding that deficiency may cause not only rickets but also contribute to the magnitude 
of childhood illness and have serious implication for future life, there is lack of information 
on vitamin D status among pre-school children in developing  countries 
(16)
. Hence, we aimed 
to assess the vitamin D status among children from 1 to 5 years old in rural Nepal, and to 
identify possible association between vitamin D status with socio-demographic indicators, 
breastfeeding practices and nutritional status in this population.  
Methods 
Study participants and setting 
This community based cross- sectional study was conducted in rural Nepal at latitude 27.39
0 
N during dry season between September and November 2012. Children from 1 to 5 years of 
age were recruited from the nine wards of Ugrachandi Nala Village Development Committee 
in Kavrepalanchowk district of Central Nepal.  As a base for sampling we used records from 
Nepal’s national vitamin A supplementation program for children aged 6 to 59 months with 
coverage of 90.4% as for 2011 
(25)
 available at local health post. Out of available records we 
created numbered list of all 411 children aged 12-60 months living at Ugrachandi Nala. By 
using online randomizer, a set of 320 unique sorted numbers was generated with range from 1 
to 411 (representing the children assigned numbers). Subjects were selected randomly 
according to the produced list of numbers. Community Health Volunteers women were 
requested to identify selected children and invite guardians for participation in the study. We 
selected 320 children in order to achieve sample size of 280 subjects.  Children with known 
metabolic bone disease, chronic disease associated with bone abnormalities or with current 
medication are likely to interfere with vitamin D metabolism were excluded from the study, as 
well as the children those guardians were not able to comply with study protocol and provide 
informed consent.  
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Ethical consideration  
Present study was approved by the Nepal Health Research Council and Regional Committee 
for Medical and Health Research in Norway.  Parents were explained about aims of the study 
and data collection procedure. Informed written or witness consent was obtained from the 
guardians of all participants. Witness consent was acquired when guardian had a decision 
making capacity but cannot read or write due to illiteracy.  Witness was an adult from the 
same community who was not a member of study team.   
 
 
Collection of Background information 
Information regarding socio-demographic characteristic such as numbers of person in the 
household, parents’ occupation, household income, as well as breastfeeding practices, milk 
product consumption and use of any vitamin supplementation, present and past child’s health 
concerns and sun exposure was gained by trained study assistant through interview with 
guardians of the child by using structured questionnaire. The socio-economic status was 
assessed based on the household income and type of housing (made from natural or 
manufactured materials).  The questionnaire was piloted among mothers at target setting. Pre-
testing showed that children do not consume any food naturally rich with vitamin D. 
Consequently, question regarding vitamin D intake was removed from the questionnaire. 
Possible answers to the questions regarding to socio-demographic indicators were labelled 
based on the given responses with the option for unexpected answer. Milk product intake was 
calculated by multiplying the amount per serving and the frequencies of consumptions for 
each type of milk product. Calcium intake was computed by multiplying the calcium content 
of the specific type of milk by the daily consumed amount. Total calcium intake from milk 
products was calculated by summing the calcium intake from different milk products for each 
child. Calcium value in milk products were obtained from USDA National Nutrient Database 
for Standard Reference  
(26)
. Weight was measured with digital weight scale made by 
Microlife Company in Swiss, certified for ISO 9001 accurate to 100g. Height was measured 
by wall stadiometer made by Bio-Plus 200cm, Model 265M/1013522. Anthropometric 
measurement were performed according to WHO Child Grow Assessment 
(27)
. 
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Collection of blood and vitamin D analysis  
Capillary blood was collected by a certified nurse after pricking the fingertip with a single use 
safety lancet. The total amount collected was approximately 0.5 ml. Blood drops were applied 
directly on the sampling filter card with pre-marked circles. The cards then were air dried 
during the first two hours; sample cards were stored in low gas –permeable zip lock bag with 
desiccant packages. Samples were kept at room temperature during the first 7 days, and later 
refrigerated. At the end of sample collection, vitamin DBS kits were shifted to the laboratory 
Vitas in Norway by DHL express for further analysis. The levels of 25(OH) D3 and 25(OH) D2 
were quantified separately by using LC-MS/MS from DBS. Punches from DBS were added 
water, shaken, and diluted with 2-propanol/methanol containing the internal standard hexa-
deuterio25-hydroxy vitamin D3 and BHT as an antioxidant. After mixing and centrifugation 
the supernatant was transferred to an insert, centrifuged again and an aliquot of 50µL was 
injected into the HPLC system. HPLC was performed with a Agilent 1200 liquid 
chromatograph (Agilent Technologies, Palo Alta, CA, USA) interfaced by atmospheric 
pressure chemical ionization to a Agilent mass spectrometric detector  operated in Multiple 
Reaction Monitoring mode. Vitamin D analogues were separated on a 4.6 mm x 150 mm 
reversed phase column with 2.7µM particles. The column temperature was 40 °C. A two-
point calibration curve was made from analysis of DBS calibrators with known vitamin D 
concentrations. The inter-assay CV is 7.6 % (35.8 nM) and 10.2 % (78.3 nM). 
The LC-MS/ MS DBS method was internally validated, it was chosen as a less invasive and 
convenient to use with paediatric groups in the field research. The laboratory performing the 
analysis is part of the Vitamin D Quality Assessment Scheme and compliant. 
For the determination of vitamin D status there is not universally accepted threshold for 
normal level of 25(OH)D3, however most experts agree that the lower limit of adequacy 
should be higher than 50nmol/l in order to avoid manifestation of rickets and osteomalacia 
(1, 
3, 28)
. Although, there is a growing agreement that the optimal level should be between 75-100 
nmol/l in order to maintain normal bone metabolism and ensure extra skeletal effects of 
vitamin D 
(29)
.  In this study we used reference range of 25(OH)D3 suggested by Lips P., 2004 
(28)
, where vitamin D deficiency subdivided on mild, moderate and severe deficiency. 
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Assessment of nutritional status  
The nutrition status of the children was determined by comparing measurements of weight for 
height, weight for age and height for age to the World Health Organization reference 
standards for wasting, underweight, and stunting indicators, respectively 
(30)
.    
1. weight-for-height (WFH) – wasting indicator (acute or recent malnutrition)  
2. weight-for-age (WFA) – underweight indicator (acute or chronic malnutrition) 
3. height-for-age (HFA) – stunting indicator (chronic or long-standing malnutrition) 
Also global acute malnutrition (wasting) is defined as <-2 z scores weight-for-height and/or 
oedema. Severe acute malnutrition is defined as <-3z scores weight-for-height and/or oedema. 
Underweight is defined as <-2z scores weight-for-age while severe underweight is defined as 
<-3z scores weight-for-age. Chronic malnutrition (stunting) is defined as <-2 z scores height-
for-age while severe chronic malnutrition is defined as <-3z scores height-for-age. 
 
Statistical analysis 
Statistical analysis of the data was performed by using PASW software (version 20, SPSS 
IBM Corporation, USA). WHO Anthro software (version 3.2.2), was used to evaluate gender 
specific growth indicators in relation to WHO standards 
(30)
.  Standing height for children 
younger than 24 months was equalized to the recumbent length by adding 0.7 cm. according 
to WHO Anthro software’s guidelines.  Data from descriptive statistic are presented as mean 
scores and standard deviation. To compare the mean scores of vitamin D level between 
categorical variables we used independent sample t-test (two-tailed). One way analysis of 
variance was performed to explore association between vitamin D concentrations with the 
categorical explanatory variables. For unequal variances the non-parametric test has been 
used (Kruskal- Wallis test, Mann-Whitney U test). Results have been considered statistically 
significant with p value below 0.05. 
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Results 
Most of the children (81.1%) from our sample (n=280; 157 boys and 123 girls) were from low 
to medium socio-economic group. The majority (95%) of the children belonged to Hindu 
families. The basic characteristics of children are given in Table 1. The vast majority of 
parents reported trousers and long sleeves shirt as regular clothing for their children; 16% 
mentioned t-shirt as an option for warm days. In our sample breastfeeding was almost 
universal (99.3%), with 107 mothers reported that child is still breastfeed. The mean duration 
for exclusive breastfeeding was estimated 6 months while the mean duration for breastfeeding 
in general was estimated at 27 months. Over half of the children in our sample were stunted, 
while nearly one-fourth were underweight.  
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Table 1, Basic characteristics of children (mean value, standard deviation, number of subjects 
and percentages) 
                                                                        Girls (n= 123)               Boys (n= 157) 
n (%) mean (SD) n (%) mean (SD) 
   
Age (months)     
     12-24 42 (34.1) − 51 (32.5) − 
     25-36 35 (28.5) − 37 (23.6) − 
     37-60 46 (37.4) − 69 (43.9) − 
Weight (kg) − 11.5 (2.5) − 12.3 (2.6) 
Height (cm) − 86.6 (10.2) − 89.1 (9.9) 
Calcium intake (mg/day) − 289 (203) − 340 (256) 
Currently breastfeed 47 (38.2) − 60 (38.2) − 
25(OH)D3 (nmol/l) − 31.2 (11.2) − 31.9 (12.6) 
Weight-for –height     
-Global acute malnutrition 4 (3.4) − 8 (5.4) − 
-Severe acute malnutrition 1 (0.8) − 2 (1.4) − 
Weight-for-age     
-Underweight 27 (22.0) − 20 (12.7) − 
-Severe underweight 8 (6.5) − 11 (7) − 
Height-for-age     
-Chronic malnutrition 37 (30.8) − 37 (23.6) − 
-Severe chronic malnutrition 21 (17.5) − 24 (16.3) − 
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Vitamin D status 
Concentration of 25(OH)D3 ranged from 6.9 to 74.5 nmol/l with a mean score of 31.6nmol/l 
(SD 12.0); Around 91.1% of the children had levels of 25(OH)D3 less than 50 nmol/l. Table 2 
classifies states of vitamin D deficiency on the basis of 25(OH)D3 levels.  As related to the 
level of 25(OH)D2 for the 96. 8% of children it was not detectable (less than 5nmol/l).  
Table 2, Vitamin D status in relation to 25(OH)D3- levels among1-5 year old children in rural 
Nepal 
Vitamin D status Cut-offs  Prevalence among study population           
                      %  (n) 
Sufficient ≥ 50 nmol/l                       8.9  (25) 
Mild deficiency 25.1-49.9 nmol/l                       61.8 (173) 
Moderate deficiency 12.6-25 nmol/l                       25.4 (71) 
Sever deficiency 0-12.5 nmol/l                       3.9   (11) 
 
There was no difference in the mean 25(OH)D3 levels between boys and girls.  The mean 
25(OH)D3 levels in those children younger than 36 months who were currently breastfeed 
(36.4 nmol/l, SD 13.2) were higher compare to those who were not (28.6 nmol/l, P=0.001). 
Younger children had mean level of 25(OH)D3  higher in comparison to the older group 
(P=0.01).  While other variables such as socio-economic indicator, measured as a monthly 
household income, gender, sun exposure and nutritional status were not associated with levels 
of 25(OH)D3 
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Table3, Characteristics of study population by 25(OH)D3 level 
Characteristic N (%) Mean 25(OH)D3  
level nmol/l 
(SD) p-
Value
* 
Gender      
Female 123 (43.9) 31.2 (11.2)  
Male 157 (56.1) 31.9 (12.6) 0.6 
Age(months)      
12-24 93 (33.2) 35.4 (13.1)  
25-36 72 (25.7) 30.8 (11.4)  
37-60 115 (41.1) 29.0 (10.7) 0.01 
Household income (monthly, 
NRS
**
) 
     
Below 14999 140 (50) 32.7 (12.2)  
15000-39999 87 (31.1) 31.1 (11.7)  
Above 40000 53 (18.9) 29.4 (11.9) 0.2 
Currently breastfeed 
(for children 12-36m) 
     
Yes 102 (61.8) 36.4 (13.2)  
No 63 (38.2) 28.6 (9.8) 0.001 
Nutritional status
      
Weight-for height      
-Corresponds to normal 251 (94.4) 31.2 (11.6)  
-Global acute malnutrition
*** 
15 (5.6) 38.2 (15.7) 0.11 
Weight-for-age      
-Corresponds to normal 214 (76.4) 31.1 (11.7)  
-Underweight 47 (16.8) 31.6 (11.4)  
-Severe underweight 19 (6.8) 37.5 (15.4) 0.98 
Height-for-age      
-Corresponds to normal 148 (55.4) 31.7 (12.2)  
-Chronic malnutrition 74 (27.7) 31.04 (11.8)  
-Severe chronic malnutrition 45 (16.9) 32.8 (11.6) 0.74 
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*
p-value was calculated by using T-test, ANOVA and Kruskal-Wallis test for non-normally 
distributed variances 
**
NRS: Nepalese Rupees. 1USD = approx. NRS 100 as of September 30, 2012. 
***
Nutritional status determined with cut-offs -2SD, includes 3 cases with score below -3SD 
Discussion  
We found that vitamin D deficiency is common among children in rural Nepal, with up to 
91.1% of children between 1-5 years of age having a 25(OH)D3 level under 50nmol/L. The 
findings of the current study are consistent with the few reports of vitamin D status among 
neonates, adolescent and adults in the region 
(20, 22, 31-33)
. Similar prevalence of vitamin D 
deficiency was identified in case-controls studies conducted among children of preschool age 
in India and Bangladesh. Wayse at al. using the same cut off for the determination of vitamin 
D status recorded vitamin D deficiency 95% and 61% for cases and controls respectively 
(34)
.  
Similarly Roth at al. indicated mean serum 25-hydroxyvitamin D concentration  29.2nmol/l 
for cases and 39.2nmol/l for controls 
(35)
. Calcium intake from milk products was recorded as 
uniformly low 318. 08 Ca mg/day (SD 235. 4), it also was observed by field stuff, children get 
quite often cow or buffalo milk and homemade yogurt but the quantities per serving is very 
small. 
Factors associated with vitamin D status 
In contrast to earlier findings, we did not find significant difference between vitamin D level’s 
in boys and in girls, as it was observed by Sahu at al. in rural India for teenagers 
(36)
, it could 
be explained that in this age group there is no difference in clothing practices and outdoor 
activities between genders. In our sample we did not observe difference in vitamin D levels of 
children between different social-economic layers, measured as income level and type of 
housings, as it was for Pakistani infants
(37)
 and Indian schoolgirls 
(32)
.  It might not be 
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appropriate to mention that discrepancy as a contradiction given the fact that the study 
population differ in age. High level of vitamin D among low socioeconomic strata explained 
with prolonged sun exposure due to occupational particularities, inversely better household 
condition and education leads to restriction of outdoor activities 
(37, 38)
. As related to our study 
population, it seems that for children in preschool age vitamin D status is not determined with 
socio-economic conditions because of similarly poor vitamin D supply in diet and comparable 
exposure to sunlight.  
In the literature exclusive long-lasting breastfeeding was reported as a risk factor for the 
development of hypovitaminosis D 
(1, 39)
. In our study we were not able to test that 
association, taking into consideration that our subjects were older than one year of old, and 
were not breastfeed exclusively.  Although, we found that children who were received breast 
milk in addition to traditional food had better vitamin D status compare to those who were 
not. Also younger children had significantly higher levels of vitamin D than those in the older 
groups. Contrary to our expectations, we did not find a significant difference in the mean 
scores of 25(OH)D3  for the children with different nutritional status.  
Even though this finding is in agreement with similar studies conducted in the region, the 
reason for this high magnitude of not adequate vitamin D status remains unclear. Several 
explanations have been postulated. These include intensive skin pigmentation, traditional diet 
poor with natural source of vitamin D, long lasting exclusively breastfeeding of infants and 
absents of national vitamin D supplementation program 
(15, 40)
.  
Limitation  
This study has several limitations. For the drawing sample from population the randomization 
was applied. Although, due to the absence of demographic data in the region, we have had to 
create our own databases from the vitamin A supplementation program, records available at 
VDC health post. It means that, children that for some reasons did not get vitamin A 
supplements during last 6 months were not included in our databases, and consequently did 
not get chance to be selected for the current study. This kind of selection bias may result that 
our sample were more representative for those who has better access to health care programs 
than for general population in total. Apparently calcium intake was not calculated accurately, 
we used reported regular consumption of milk products, but we accept that it might be 
recalled inaccurately, also, we did not count other sources of calcium in the diet.  
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 Question regarding sun exposure was not enough detailed, it did not clarify time of being 
outside during the day. It is important due to the effect on the vitamin D production in the skin 
under the impact of UVB. Another aspect that affects the quality of data is approximation in 
the age of children. Nepalese people do not register children immediately after birth. Situation 
with clarifying an age was aggravated because of differences in calendar year, between 
lunisolar Hindu calendar officially used in Nepal and western Gregorian one. So, we 
registered the age of the child based on the mother’s claiming, but we accept deviations of 6-
12 months. Yet another limitation is that we, for weight and height measurements used 
equipment that were not standardised for establishing of anthropometric databases. It might be 
considered as a limitation the absence of data on the level of calcium, phosphorus and alkaline 
phosphatase from our study population. Although, these indicators are more relevant to the 
assessment of bone metabolism and deviate during severe vitamin D deficiency. In fact, 
simple measurement of 25-hydroxyvitamin D3 reflects the objectives of our study to assess the 
vitamin D status of children.  
Despite of these limitations this study shapes general pattern of vitamin D status among pre-
school children in rural Nepal. It was designed with adequate power and sufficient sample 
size for the first time among pre-school children in the region. Full sample size was achieved 
with respond rate of 87.5%, vitamin D status was assessed with DBS method internally 
validated.  However we should take into consideration that Nepal is country with tremendous 
diversity in altitude, which has effect on the vitamin D production through the whole year 
(41)
. 
Therefore this result needs to be interpreted with respect to study population and geographical 
coordinates.   
Conclusion 
We report high prevalence of vitamin D deficiency among pre-school children in rural area of 
Nepal at latitude 27.39
0
 N. In our sample, socio-demographic factors did not affect on vitamin 
D status of children, but prolonged breastfeeding practices in late infancy was associated with 
better vitamin D level. Further research is required to investigate the health consequences of 
low vitamin D status for this population.  
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